Cargando…
Case Report: Therapeutic Threshold for Rifampicin-Resistant Tuberculosis in a Patient from Maputo, Mozambique
We present a case of a patient in Mozambique, who initiated treatment for rifampicin-resistant tuberculosis (RR-TB) without proof of resistance. For this patient, we estimated the probability of RR-TB using likelihood ratios of clinical arguments. The probability of RR-TB in Mozambique, positive HIV...
Autores principales: | Gonzaga, Lorena D. M., Gils, Tinne, Decroo, Tom, Jacobs, Bart K. M., Lynen, Lutgarde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045612/ https://www.ncbi.nlm.nih.gov/pubmed/33556043 http://dx.doi.org/10.4269/ajtmh.20-0959 |
Ejemplares similares
-
The therapeutic threshold in clinical decision-making for TB
por: de Rooij, Madeleine L, et al.
Publicado: (2023) -
Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi
por: Ciza, François, et al.
Publicado: (2020) -
Attrition one year after starting antiretroviral therapy before and after the programmatic implementation of HIV “Treat All” in Sub-Saharan Africa: a systematic review and meta-analysis
por: Makurumidze, Richard, et al.
Publicado: (2023) -
High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020) -
Mycobacterium tuberculosis causing tuberculous lymphadenitis in Maputo, Mozambique
por: Viegas, Sofia Omar, et al.
Publicado: (2015)